Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My NCBI Filters

Text availability

Article attribute

Article type

Publication date

Search Results

533 results

Filters applied: . Clear all
Results are displayed in a computed author sort order. The Results By Year timeline is not available.
Page 1
Long-term subcutaneous interferon beta-1a therapy in patients with relapsing-remitting MS.
Kappos L, Traboulsee A, Constantinescu C, Erälinna JP, Forrestal F, Jongen P, Pollard J, Sandberg-Wollheim M, Sindic C, Stubinski B, Uitdehaag B, Li D. Kappos L, et al. Among authors: constantinescu c. Neurology. 2006 Sep 26;67(6):944-53. doi: 10.1212/01.wnl.0000237994.95410.ce. Neurology. 2006. PMID: 17000959 Clinical Trial.
Spinal cord atrophy and disability in multiple sclerosis over four years: application of a reproducible automated technique in monitoring disease progression in a cohort of the interferon beta-1a (Rebif) treatment trial.
Lin X, Tench CR, Turner B, Blumhardt LD, Constantinescu CS. Lin X, et al. Among authors: constantinescu cs. J Neurol Neurosurg Psychiatry. 2003 Aug;74(8):1090-4. doi: 10.1136/jnnp.74.8.1090. J Neurol Neurosurg Psychiatry. 2003. PMID: 12876240 Free PMC article. Clinical Trial.
Deep gray matter and fatigue in MS: a T1 relaxation time study.
Niepel G, Tench ChR, Morgan PS, Evangelou N, Auer DP, Constantinescu CS. Niepel G, et al. Among authors: constantinescu cs. J Neurol. 2006 Jul;253(7):896-902. doi: 10.1007/s00415-006-0128-9. Epub 2006 Mar 13. J Neurol. 2006. PMID: 16525881
Repeated subcutaneous injections of IL12/23 p40 neutralising antibody, ustekinumab, in patients with relapsing-remitting multiple sclerosis: a phase II, double-blind, placebo-controlled, randomised, dose-ranging study.
Segal BM, Constantinescu CS, Raychaudhuri A, Kim L, Fidelus-Gort R, Kasper LH; Ustekinumab MS Investigators. Segal BM, et al. Lancet Neurol. 2008 Sep;7(9):796-804. doi: 10.1016/S1474-4422(08)70173-X. Lancet Neurol. 2008. PMID: 18703004 Clinical Trial.
Methylprednisolone in combination with interferon beta-1a for relapsing-remitting multiple sclerosis (MECOMBIN study): a multicentre, double-blind, randomised, placebo-controlled, parallel-group trial.
Ravnborg M, Sørensen PS, Andersson M, Celius EG, Jongen PJ, Elovaara I, Bartholomé E, Constantinescu CS, Beer K, Garde E, Sperling B. Ravnborg M, et al. Lancet Neurol. 2010 Jul;9(7):672-80. doi: 10.1016/S1474-4422(10)70132-0. Epub 2010 Jun 9. Lancet Neurol. 2010. PMID: 20542736 Clinical Trial.
533 results